D2-40 as a diagnostic marker for pulmonary squamous cell carcinoma

K. H. Min, Y. C. Lee, S. J. Park, M. J. Chung, S. R. Kim, M. H. Lee, C. R. Chung, H. J. Han, W. S. Lee (Jeonju, Republic Of Korea)

Source: Annual Congress 2010 - Pathology of lung cancer
Session: Pathology of lung cancer
Session type: Thematic Poster Session
Number: 3260
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. H. Min, Y. C. Lee, S. J. Park, M. J. Chung, S. R. Kim, M. H. Lee, C. R. Chung, H. J. Han, W. S. Lee (Jeonju, Republic Of Korea). D2-40 as a diagnostic marker for pulmonary squamous cell carcinoma. Eur Respir J 2010; 36: Suppl. 54, 3260

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Angiogenic squamous dysplasia: highly associated with squamous cell lung carcinoma
Source: Annual Congress 2006 - Biological features, lung function and treatment of lung cancer
Year: 2006

Bilateral squamous cell carcinoma
Source: Annual Congress 2008 - Various thoracic tumours and interesting cases
Year: 2008

Karyometric analysis of squamous metaplasia, dysplasia and squamous cell carcinoma of the lung
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement
Source: Eur Respir J 2007; 30: 21-26
Year: 2007



Proposal of a prognostically relevant grading scheme for pulmonary squamous cell carcinoma
Source: Eur Respir J 2016; 47: 938-946
Year: 2016



COX-2 expression during early lung squamous cell carcinomas oncogenesis
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005

Borderline early squamous cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=157
Year: 2004

Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis
Source: Eur Respir J 2008; 31: 854-859
Year: 2008



The value of AXL expression in squamous cell carcinoma of the lung: relationship with clinicopathological parameters.
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017

Comparing LYVE-1 and D2-40 expression in small cell lung carcinomas (SCLC); association with clinical parameters and lymphatic invasion
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011

Karyometric analysis of bronchioloalveolar carcinoma (BAC) and adenocarcinoma of the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 91s
Year: 2006

Pathology and immunohistochemistry of lung cancer
Source: Eur Respir Mon; 2009: 44: 15–35
Year: 2009

Prognostic value of three-microRNA expression profile in early stage squamous cell lung cancer (SqCLC)
Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer
Year: 2010

COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 361s
Year: 2003

Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


An analysis of mRNA and long non-coding RNA (lncRNA) expression during the progression from pre-invasive lesions (PL) to invasive squamous cell carcinoma (SqCC) of the bronchus
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013


Large cell neuroendocrine carcinoma of the lung: Experience with 20 resected cases
Source: Eur Respir J 2003; 22: Suppl. 45, 250s
Year: 2003